European Biotech Award Presented to Cancer Drug Specialist
Feb 07 2019 Read 501 Times
Clinical-stage biotechnology company Genoscience Pharma, dedicated to discovering and developing anticancer drugs, received the Most Innovative European Biotech SME Award for 2018 in the Healthcare category at EuropaBio.
The Marseille-based company’s new therapy with an activity against cancer stem cells, is currently in an international Phase 1/2 trial in liver cancer (US and Europe). Genoscience Pharma’s drug candidate has the potential to be combined with any other anti-cancer therapy (chemotherapy, immunotherapy, targeted therapies and cell-gene therapy).
The panel for the ninth edition of the EuropaBio Most Innovative European Biotech SME Awards, assessed 40 companies from across the EU, acknowledging their outstanding contribution towards tackling significant challenges through the application of biotechnology.
“Genoscience Pharma is delighted to receive such recognition of its work. We truly believe we can make the difference in cancer treatment with our innovative discovery, the first clinical-stage oral drug with an action on cancer stem cells. As we continue to face significant financing and regulatory barriers, this prize is an important opportunity to demonstrate our work. It will help us to further develop our technology,” said Philippe Halfon, CEO of Genoscience Pharma. “Cancer is probably the most important challenge for humanity. This recognition is one small step for our company but an important step in the fight against cancer.”
“For all the Genoscience Pharma team, this prize is a recognition of our hard work. We are delighted to see our efforts awarded, and this shows that no matter the size of a company, with motivation, strength and passion, we can reach our goals,” said Cindy Khaldi, translational science manager at Genoscience Pharma. “We are now looking forward to being able to spread our innovation worldwide to treat patients.”
For information on the EuropaBio Awards visit www.europabio.org
Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.
In this Issue Articles Mass Spectrometry & Spectroscopy 67th ASMS Conference on Mass Spectrometry and Allied Topics Chromatography Using Gas Chromatography for measuring atmo...
View all digital editions
Aug 25 2019 San Diego, CA, USA
Sep 01 2019 Berlin, Germany
Sep 03 2019 Manchester, UK
Sep 04 2019 Chiba City, Japan
Sep 08 2019 Krakow, Poland